Bhupinder Singh

Bhupinder Singh, MD, currently serves as Chief Medical Officer at Rénibus Therapeutics Inc. and has held the position of Clinical Professor in the Department of Medicine at the University of California, Irvine since May 2017. As a Co-Founder of Nephcentric and RENIBUS THERAPEUTICS, INC., and a Scientific Advisor for AseptiScope™, Bhupinder Singh contributes significant expertise to various organizations. Previous roles include Vice President of Clinical Development and Medical Affairs at Allakos Inc. and Clinical Advisor at Cricket Health. Bhupinder Singh is actively involved in multiple advisory and board positions, including the Cardio Renal Society of America and PatienTrials. Educational credentials encompass a Bachelor of Medicine, Bachelor of Surgery from Armed Forces Medical College and professional training from prestigious institutions such as Harvard T.H. Chan School of Public Health and Wharton Online.